HIV treatment as prevention: To be or not to be?

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 2, 2010, Pages 137-138

  Cohen, Myron S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NOTE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; HIV INFECTIONS;

ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 77957322879     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181f0cbf3     Document Type: Note

References (19)

1. WHO. Towards universal access: scaling up priorityHIV/AIDS interventions in the health sector. Progress Report. Vol 2007: Available at: http://www.who. int/hiv/mediacentre/universal-access-progress-report-en.pdf. 2007. Accessed June 30, 2010.
2. Cohen MS, Gay C, Kashuba AD, et al. Narrative review: Antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007;146:591-601.
3. Mofenson LM. Protecting the next generation-eliminationg perinatal HIV- 1 infection. N Engl J Med. 2010;362:2316-2318.
4. Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS. 2006;20:85-92.
5. Sullivan P, Kayitenkore K, Chomba E, et al. Reduction of HIV transmission risk and high risk sex while prescribed ART: results from discordant couples in Rwanda and Zambia. Presented at: 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada. Abstract 52bLB.
6. Del Romero J, Castilla J, Hernando C, et al. Combined antiretroviral therapy and heterosexual transmission of HIV: cross-sectional and prospective cohort study. Br Med J. 2010;340:c2205 (online first).
7. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission of antiretroviral therapy: A prospective cohort analysis. Lancet. 2010;375:2092-2098.
8. Fang CT, Hsu HM, Twu SJ, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis. 2004;190:879-885
9. Montaner J, Wood E, Kerr T, et al. Association of expanded HAART coverage with a decrease in new cases of HIV, particularly among injection drug users in British Columbia, Canada. Presented at: 17th Conference on Retroviruses and Opportunitistic Infection; February 16- 19, 2010; San Francisco CA; Abstract LB88.
10. Das, M, Cu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5:e11068.
11. Fang CT, Hsu HM, Twu SJ, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis. 2004;190:879-885.
12. Bezemer D, de Wolf F, Boerlijst M, et al. Despite HAART, HIV-1 is once again spreading among men havis sex with men in the Netherlands. Presented at: 17th Conference on Retroviruses and Opportunitistic Infection; February 16-19, 2010; San Francisco CA. Abstract 151.
13. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet. 2009;373:48-57.
14. Smith RJ, Okano JT, Kahn JS, et al. Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco. Science. 2010;327: 697-701.
15. Miller WC, Rosenberg E, Rutstein SE, et al. Role of acute and early HIV infection in the sexual transmission of HIV. Curr Opin HIV AIDS. 2010;5:277-282.
16. Pisani E. One HIV test, but two results. Available at: http:// www.guardian.co.uk/commentisfree/2010/feb/22/the-drugs-wont-work. Accessed June 30, 2010.
17. Wang L, Ge Z, Luo S, et al. HIV transmission risk among serodiscordant couples: A retrospective study of former plasma. J Acquir Immune Defic Syndr. 2010;55:232-238.
18. Li N,Wang Z, Sun D, et al. HIVamong plasma donors and other high-risk groups in Henan, China. J Acquir Immune Defic Syndr. 2010;53:S41-S47.
19. Cohen MS, Gay C. Treatment to prevent HIV transmission. Clin Infect Dis. 2010;50(Suppl 3):S85-S95.